Zusammenfassung
Die postoperative Endophthalmitis bleibt eine der gefürchtetsten Komplikationen und Notfallsituationen für Augenärzte, obwohl ein unverzügliches therapeutisches Einschreiten die Sehleistung wiederherstellen kann. Die absolute Zunahme an Infektionen nach intraokularen Eingriffen macht die Endophthalmitis zu einem aktuellen Thema. Früher hat man sich oft auf Infektionen nach stattgefundener Kataraktchirurgie bezogen – Diese werden jedoch einerseits aufgrund der Fortschritte in der Kataraktchirurgie, andererseits aufgrund der demografischen Entwicklung mit einer stetig steigenden Anzahl an intravitrealen Injektionen relativ gesehen weniger. In diesem Beitrag werden die Formen der postoperativen Endophthalmitiden im Hinblick auf Pathophysiologie und ihre spezifischen Merkmale in Abhängigkeit von ihrer genauen Ätiologie untersucht.
Abstract
Postoperative endophthalmitis is one of the most feared complications for ophthalmologists, and the number of infections after intraocular procedures have been increasing. Nonetheless, a prompt intervention can result in the recovery of vision. In the past, endophthalmitis after cataract surgery was accountable for the majority of cases but is becoming less frequent due to the progress of surgical techniques and demographic developments with a steadily increasing number of intravitreal injections. In this article, the different forms of postoperative endophthalmitis are assessed in terms of pathophysiology and their specific characteristics depending on their etiology.
Literatur
Becker MD, Mackensen F (2007) Treatment of acute postoperative endophthalmitis. New aspects in an emergency situation. Ophthalmologe 104(11):947–951
Maalouf F, Abdulaal M, Hamam RN (2012) Chronic postoperative endophthalmitis: a review of clinical characteristics, microbiology, treatment strategies, and outcomes. Int J Inflam 2012:313248
Al-Mezaine HS, Al-Assiri A, Al-Rajhi AA (2009) Incidence, clinical features, causative organisms, and visual outcomes of delayed-onset pseudophakic endophthalmitis. Eur J Ophthalmol 19(5):804–811
Meisler DM, Palestine AG, Vastine DW, Demartini DR, Murphy BF, Reinhart WJ et al (1986) Chronic propionibacterium endophthalmitis after extracapsular cataract extraction and Intraocular lens implantation. Am J Ophthalmol 102(6):733–739
Shirodkar AR, Pathengay A, Flynn HW Jr., Albini TA, Berrocal AM, Davis JL et al (2012) Delayed- versus acute-onset endophthalmitis after cataract surgery. Am J Ophthalmol 153(3):391–398e2
Group EVS (1995) Results of the endophthalmitis vitrectomy study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial Endophthalmitis. Arch Ophthalmol 113(12):1479–1496
Maneschg O, Csakany B, Nemeth J (2009) Ultrasonographische Befunde bei Endophthalmitis nach Kataraktoperationen : Rückblick auf 81 Falle. Ophthalmologe 106(11):1012–1015
Roth DB, Chieh J, Spirn MJ, Green SN, Yarian DL, Chaudhry NA (2003) Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 121(9):1279–1282
Marticorena J, Romano V, Gomez-Ulla F (2012) Sterile endophthalmitis after intravitreal injections. Mediators Inflamm 2012:928123
Stewart JM, Srivastava SK, Fung AE, Mahmoud TH, Telander DG, Hariprasad SM et al (2011) Bacterial contamination of needles used for intravitreal injections: a prospective, multicenter study. Ocul Immunol Inflamm 19(1):32–38
Tufan HA, Vural A, Gencer B, Kara S, Arikan S, Yuksel E (2013) Bacterial contamination of needles used for intravitreal injections: comparison between 27-gauge and 30-gauge needles. Ocul Immunol Inflamm 21(5):366–370
de Caro JJ, Ta CN, Ho HK, Cabael L, Hu N, Sanislo SR et al (2008) Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections. Retina 28(6):877–883
Czajka MP, Byhr E, Olivestedt G, Olofsson EM (2016) Endophthalmitis after small-gauge vitrectomy: a retrospective case series from Sweden. Acta Ophthalmol 94(8):829–835
Callegan MC, Booth MC, Jett BD, Gilmore MS (1999) Pathogenesis of gram-positive bacterial endophthalmitis. Infect Immun 67(7):3348–3356
Kumar A, Kumar A (2015) Role of staphylococcus aureus virulence factors in inducing inflammation and vascular permeability in a mouse model of bacterial Endophthalmitis. PLoS ONE 10(6):e128423
Ng EW, Costa JR, Samiy N, Ruoff KL, Connolly E, Cousins FV et al (2002) Contribution of pneumolysin and autolysin to the pathogenesis of experimental pneumococcal endophthalmitis. Retina 22(5):622–632
McLaughlin MD, Hwang JC (2017) Trends in Vitreoretinal Procedures for Medicare Beneficiaries, 2000 to 2014. Ophthalmology 124(5):667–673
Storey PP, Patel D, Garg S (2020) Endophthalmitis following intravitreal injection of anti-vascular endothelial growth factor agents. Can J Ophthalmol 55(4):286–292
Bhavsar AR, Googe JM Jr., Stockdale CR, Bressler NM, Brucker AJ, Elman MJ et al (2009) Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials. Arch Ophthalmol 127(12):1581–1583
Inoue M, Kobayakawa S, Sotozono C, Komori H, Tanaka K, Suda Y et al (2011) Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor. Ophthalmologica 226(3):145–150
Bhavsar AR, Sandler DR (2015) Eliminating antibiotic prophylaxis for intravitreal injections: a consecutive series of 18,839 injections by a single surgeon. Retina 35(4):783–788
Storey PP, Tauqeer Z, Yonekawa Y, Todorich B, Wolfe JD, Shah SP et al (2019) The impact of prefilled syringes on endophthalmitis following Intravitreal injection of Ranibizumab. Am J Ophthalmol 199:200–208
Garg SJ, Dollin M, Hsu J, Storey P, Vander JF (2015) Effect of a strict “no-talking” policy during Intravitreal injection on post-injection endophthalmitis. Ophthalmic Surg Lasers Imaging Retina 46(10):1028–1034
Lyall DA, Tey A, Foot B, Roxburgh ST, Virdi M, Robertson C et al (2012) Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes. Eye 26(12):1517–1526
Levinson JD, Garfinkel RA, Berinstein DM, Flory M, Spellman FA (2018) Timing of povidone-iodine application to reduce the risk of endophthalmitis after Intravitreal injections. Ophthalmol Retina 2(7):654–658
Rayess N, Rahimy E, Shah CP, Wolfe JD, Chen E, DeCroos FC et al (2016) Incidence and clinical features of post-injection endophthalmitis according to diagnosis. Br J Ophthalmol 100(8):1058–1061
Rayess N, Rahimy E, Storey P, Shah CP, Wolfe JD, Chen E et al (2016) Postinjection endophthalmitis rates and characteristics following intravitreal Bevacizumab, Ranibizumab, and Aflibercept. Am J Ophthalmol 165:88–93
Bavinger JC, Yu Y, VanderBeek BL (2019) Comparative risk of endophthalmitis after Intravitreal injection with Bevacizumab, Aflibercept, and Ranibizumab. Retina 39(10):2004–2011
Borkar DS, Obeid A, Su DC, Storey PP, Gao X, Regillo CD et al (2018) Endophthalmitis rates after bilateral same-day Intravitreal anti-vascular endothelial growth factor injections. Am J Ophthalmol 194:1–6
Juncal VR, Francisconi CLM, Altomare F, Chow DR, Giavedoni LR, Muni RH et al (2019) Same-day bilateral Intravitreal anti-vascular endothelial growth factor injections: experience of a large Canadian retina center. Ophthalmologica 242(1):1–7
Davis RP, Schefler AC, Murray TG (2010) Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration. Clin Ophthalmol 4:703–707
Milder E, Vander J, Shah C, Garg S (2012) Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection. Ophthalmology 119(7):1420–1424
Simunovic MP, Rush RB, Hunyor AP, Chang AA (2012) Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. Br J Ophthalmol 96(6):862–866
Shoaib KK, Hing S (2012) Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery. Br J Ophthalmol 96(10):1349–1350
Rahmani S, Eliott D (2018) Postoperative endophthalmitis: a review of risk factors, prophylaxis, incidence, microbiology, treatment, and outcomes. Semin Ophthalmol 33(1):95–101
Taban M, Behrens A, Newcomb RL, Nobe MY, Saedi G, Sweet PM et al (2005) Acute endophthalmitis following cataract surgery: a systematic review of the literature. Arch Ophthalmol 123(5):613–620
Li A, Shao J, Gans R, Bena J, Goshe J (2019) Postoperative endophthalmitis before and after preferred utilization of prophylactic intracameral antibiotics for phacoemulsification cataract surgeries at cole eye institute. Eye Contact Lens 45(5):306–309
Haripriya A, Chang DF, Ravindran RD (2017) Endophthalmitis reduction with Intracameral moxifloxacin prophylaxis: analysis of 600 000 surgeries. Ophthalmology 124(6):768–775
Herrinton LJ, Shorstein NH, Paschal JF, Liu L, Contreras R, Winthrop KL et al (2016) Comparative effectiveness of antibiotic prophylaxis in cataract surgery. Ophthalmology 123(2):287–294
Lundstrom M, Friling E, Montan P (2015) Risk factors for endophthalmitis after cataract surgery: predictors for causative organisms and visual outcomes. J Cataract Refract Surg 41(11):2410–2416
Grzybowski A (2017) Re: Javitt JC: Intracameral antibiotics reduce the risk of endophthalmitis after cataract surgery: does the preponderance of the evidence mandate a global change in practice? (Ophthalmology 2016;123:226–231). Ophthalmology 124(1):e8–e9
Pershing S, Lum F, Hsu S, Kelly S, Chiang MF, Rich WL 3rd et al (2020) Endophthalmitis after cataract surgery in the United States: a report from the intelligent research in sight registry, 2013–2017. Ophthalmology 127(2):151–158
Ho PC, Tolentino FI (1984) Bacterial endophthalmitis after closed vitrectomy. Arch Ophthalmol 102(2):207–210
Aaberg TM Jr., Flynn HW Jr., Schiffman J, Newton J (1998) Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. Ophthalmology 105(6):1004–1010
Cohen SM, Flynn HW Jr., Murray TG, Smiddy WE (1995) Endophthalmitis after pars plana vitrectomy. The postvitrectomy endophthalmitis study group. Ophthalmology 102(5):705–712
Zhang S, Ding X, Hu J, Gao R (2003) Clinical features of endophthalmitis after vitreoretinal surgery. Yen Ko Hsueh Pao 19(1):39–43
Eifrig CW, Scott IU, Flynn HW Jr., Smiddy WE, Newton J (2004) Endophthalmitis after pars plana vitrectomy: Incidence, causative organisms, and visual acuity outcomes. Am J Ophthalmol 138(5):799–802
Joondeph BC, Blanc JP, Polkinghorne PJ (2005) Endophthalmitis after pars plana vitrectomy: a New Zealand experience. Retina 25(5):587–589
Mollan SP, Mollan AJ, Konstantinos C, Durrani OM, Butler L (2009) Incidence of endophthalmitis following vitreoretinal surgery. Int Ophthalmol 29(3):203–205
Wykoff CC, Parrott MB, Flynn HW Jr., Shi W, Miller D, Alfonso EC (2010) Nosocomial acute-onset postoperative endophthalmitis at a university teaching hospital (2002–2009). Am J Ophthalmol 150(3):392–398e2
Park JC, Ramasamy B, Shaw S, Prasad S, Ling RH (2014) A prospective and nationwide study investigating endophthalmitis following pars plana vitrectomy: incidence and risk factors. Br J Ophthalmol 98(4):529–533
Kunimoto DY, Kaiser RS, Wills Eye Retina S (2007) Incidence of endophthalmitis after 20- and 25-gauge vitrectomy. Ophthalmology 114(12):2133–2137
Shaikh S, Ho S, Richmond PP, Olson JC, Barnes CD (2007) Untoward outcomes in 25-gauge versus 20-gauge vitreoretinal surgery. Retina 27(8):1048–1053
Chen JK, Khurana RN, Nguyen QD, Do DV (2009) The incidence of endophthalmitis following transconjunctival sutureless 25- vs 20-gauge vitrectomy. Eye (Lond) 23(4):780–784
Shimada H, Nakashizuka H, Hattori T, Mori R, Mizutani Y, Yuzawa M (2008) Incidence of endophthalmitis after 20- and 25-gauge vitrectomy causes and prevention. Ophthalmology 115(12):2215–2220
Hu AY, Bourges JL, Shah SP, Gupta A, Gonzales CR, Oliver SC et al (2009) Endophthalmitis after pars plana vitrectomy a 20- and 25-gauge comparison. Ophthalmology 116(7):1360–1365
Scott IU, Flynn HW Jr., Acar N, Dev S, Shaikh S, Mittra RA et al (2011) Incidence of endophthalmitis after 20-gauge vs 23-gauge vs 25-gauge pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol 249(3):377–380
Scott IU, Flynn HW Jr., Dev S, Shaikh S, Mittra RA, Arevalo JF et al (2008) Endophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: incidence and outcomes. Retina 28(1):138–142
Parolini B, Romanelli F, Prigione G, Pertile G (2009) Incidence of endophthalmitis in a large series of 23-gauge and 20-gauge transconjunctival pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol 247(7):895–898
Haas A, Seidel G, Steinbrugger I, Maier R, Gasser-Steiner V, Wedrich A et al (2010) Twenty-three-gauge and 20-gauge vitrectomy in epiretinal membrane surgery. Retina 30(1):112–116
Aylward GW (2011) Sutureless vitrectomy. Ophthalmologica 225(2):67–75
Fujii GY, De Juan E Jr., Humayun MS, Chang TS, Pieramici DJ, Barnes A et al (2002) Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery. Ophthalmology 109(10):1814–1820
Acar N, Kapran Z, Unver YB, Altan T, Ozdogan S (2008) Early postoperative hypotony after 25-gauge sutureless vitrectomy with straight incisions. Retina 28(4):545–552
Chen D, Lian Y, Cui L, Lu F, Ke Z, Song Z (2010) Sutureless vitrectomy incision architecture in the immediate postoperative period evaluated in vivo using optical coherence tomography. Ophthalmology 117(10):2003–2009
Kaiser RS, Prenner J, Scott IU, Brucker AJ, Flynn HW Jr., Williams GA, et al. The Microsurgical Safety Task Force (2010) evolving guidelines for minimizing the risk of endophthalmitis associated with microincisional vitrectomy surgery. Retina 30(4):692–699
Nagpal M, Wartikar S, Nagpal K (2009) Comparison of clinical outcomes and wound dynamics of sclerotomy ports of 20, 25, and 23 gauge vitrectomy. Retina 29(2):225–231
Chen SD, Mohammed Q, Bowling B, Patel CK (2004) Vitreous wick syndrome—a potential cause of endophthalmitis after intravitreal injection of triamcinolone through the pars plana. Am J Ophthalmol 137(6):1159–1160 (author reply 60–1)
Chiang A, Kaiser RS, Avery RL, Dugel PU, Eliott D, Shah SP et al (2011) Endophthalmitis in microincision vitrectomy: outcomes of gas-filled eyes. Retina 31(8):1513–1517
Abi-Ayad N, Gambrelle J, Duquesne N, Fleury J, Grange JD, Kodjikian L (2007) Endophthalmitis after plana vitrectomy: incidence, microbiology, and visual outcome. J Fr Ophtalmol 30(4):397–402
Ticho U, Ophir A (1993) Late complications after glaucoma filtering surgery with adjunctive 5‑fluorouracil. Am J Ophthalmol 115(4):506–510
Zahid S, Musch DC, Niziol LM, Lichter PR, Collaborative Initial Glaucoma Treatment Study G (2013) Risk of endophthalmitis and other long-term complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS). Am J Ophthalmol 155(4):674–680e1
Olayanju JA, Hassan MB, Hodge DO, Khanna CL (2015) Trabeculectomy-related complications in Olmsted county, Minnesota, 1985 through 2010. JAMA Ophthalmol 133(5):574–580
Wallin O, Al-ahramy AM, Lundstrom M, Montan P (2014) Endophthalmitis and severe blebitis following trabeculectomy. Epidemiology and risk factors; a single-centre retrospective study. Acta Ophthalmol 92(5):426–431
Relhan N, Forster RK, Flynn HW Jr. (2018) Endophthalmitis: then and now. Am J Ophthalmol 187:xx–xxvii
Song A, Scott IU, Flynn HW Jr., Budenz DL (2002) Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology 109(5):985–991
Caronia RM, Liebmann JM, Friedman R, Cohen H, Ritch R (1996) Trabeculectomy at the inferior limbus. Arch Ophthalmol 114(4):387–391
Razeghinejad MR, Havens SJ, Katz LJ (2017) Trabeculectomy bleb-associated infections. Surv Ophthalmol 62(5):591–610
Gedde SJ, Scott IU, Tabandeh H, Luu KK, Budenz DL, Greenfield DS et al (2001) Late endophthalmitis associated with glaucoma drainage implants. Ophthalmology 108(7):1323–1327
Topouzis F, Yu F, Coleman AL (1998) Factors associated with elevated rates of adverse outcomes after cyclodestructive procedures versus drainage device procedures. Ophthalmology 105(12):2276–2281
Zheng CX, Moster MR, Khan MA, Chiang A, Garg SJ, Dai Y et al (2017) Infectious endophthalmitis after glaucoma drainage implant surgery: clinical features, microbial spectrum, and outcomes. Retina 37(6):1160–1167
Chen JY, Jones MN, Srinivasan S, Neal TJ, Armitage WJ, Kaye SB et al (2015) Endophthalmitis after penetrating keratoplasty. Ophthalmology 122(1):25–30
Guss RB, Koenig S, De La Pena W, Marx M, Kaufman HE (1983) Endophthalmitis after penetrating keratoplasty. Am J Ophthalmol 95(5):651–658
Kloess PM, Stulting RD, Waring GO 3rd, Wilson LA (1993) Bacterial and fungal endophthalmitis after penetrating keratoplasty. Am J Ophthalmol 115(3):309–316
Aiello LP, Javitt JC, Canner JK (1993) National outcomes of penetrating keratoplasty. Risks of endophthalmitis and retinal detachment. Arch Ophthalmol 111(4):509–513
Borkar DS, Wibbelsman TD, Buch PM, Rapuano SB, Obeid A, Ho AC et al (2019) Endophthalmitis rates and clinical outcomes following penetrating and endothelial keratoplasty. Am J Ophthalmol 205:82–90
Taban M, Behrens A, Newcomb RL, Nobe MY, McDonnell PJ (2005) Incidence of acute endophthalmitis following penetrating keratoplasty: a systematic review. Arch Ophthalmol 123(5):605–609
Versura P, Giannaccare G, Pellegrini M, Sebastiani S, Campos EC (2018) Neurotrophic keratitis: current challenges and future prospects. Eye Brain 10:37–45
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
L. Bisorca-Gassendorf, K.T. Boden, P. Szurman, S. Al-Nawaiseh, A. Rickmann und K. Januschowski geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Rights and permissions
About this article
Cite this article
Bisorca-Gassendorf, L., Boden, K.T., Szurman, P. et al. Postoperative Endophthalmitis im Spiegel der Literatur. Ophthalmologe 118, 210–218 (2021). https://doi.org/10.1007/s00347-020-01271-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-020-01271-7